Exhaled nitric oxide (FeNO) has been associated with bronchial eosinophilia and with airway hyperresponsiveness (AHR) in mild stable asthma. We previously demonstrated in a large project that allergen exposure is able to raise FeNO and to worsen AHR to bradykinin. We postulated that allergen-induced increase in FeNO could be related to heightened mucosal eosinophils and AHR to bradykinin in atopic asthma. We performed a new immunohistochemical analysis on bronchial biopsy specimens, previously obtained from the same large project, in order to assess the number of mucosal eosinophils (EG-r cell) and other inflammatory cells at 48 hours after diluent and allergen exposures. Inflammatory cell counts were related to FeNO and AHR to BK (expressed as logPD 2o bradykinin). In 10 atopic mild asthmatics, we found that the numbers of EG-r and CD4+ cells in bronchial submucosa were significantly increased after allergen compared to the respective counts after diluent (p < 0.01). EG-r cells in the bronchial submucosa were negatively correlated with logPD 2o bradykinin only after allergen challenge (rho = -0.709, I? = 0.027). We also found a positive strong correlation between EG-r cells and FeNO values in atopic asthmatics at 48 hours after both diluent (rho = 0.746, P = 0.017) and allergen (rho = 0.644, P = 0.049) challenge. FeNO values negatively correlated with responsiveness to bradykinin only after allergen challenge (rho = -0.675, P = 0.039). This study indicates that after allergen exposure heightened level of exhaled NO may reflect augmented airway eosinophilic inflammation and airway responsiveness to bradykinin indicating loss of asthma control.A plethora of studies, by using bronchial mucosal biopsies, have demonstrated that bronchial asthma is a chronic inflammatory disease of the airways characterized by the presence of an array of activated inflammatory cells and mediators. Biopsy specimens from proximal bronchi obtained through a fiberoptic bronchoscope are the most direct method of measuring airway inflammation and are considered the "gold standard" for assessment of airway inflammation in asthma against which other